ECM
TELA icon

ExodusPoint Capital Management’s TELA Bio TELA Stock Holding History

ExodusPoint Capital Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-21,570
Closed -$280K – 2223
2020
Q2 		$280K Buy
+21,570
New +$283K 0.01% 1353

Other funds holding TELA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

ExodusPoint Capital Management's TELA Position: Q3 2020 in Review

ExodusPoint Capital Management sold out of TELA Bio (TELA) in Q3 2020, closing a stake of 21,570 shares — an estimated $280K sold.

ExodusPoint Capital Management first reported a position in TELA in Q2 2020 and held it in 1 quarter. The position peaked at $280K in Q2 2020. 44 funds tracked by Wall St. Rank hold TELA as of Q3 2020.

  • ExodusPoint Capital Management reported no remaining TELA Bio position as of Q3 2020 after selling out during the quarter.
  • ExodusPoint Capital Management sold 21,570 TELA Bio shares in Q3 2020, an estimated $280K.
  • ExodusPoint Capital Management first reported a position in TELA Bio in Q2 2020 and held it in 1 quarter.
  • ExodusPoint Capital Management's TELA Bio position peaked at $280K in Q2 2020.
  • 44 funds tracked by Wall St. Rank held TELA Bio as of Q3 2020.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.